Weekly recombinant FIX prophylaxis for severe haemophilia B in normal clinical practice: data from UKHCDO and Finland.

Abstract

HaemophiliaVolume 23, Issue 3 p. e240-e243 Letter to the Editor Weekly recombinant FIX prophylaxis for severe haemophilia B in normal clinical practice: data from UKHCDO and Finland M. Scott, M. Scott The Institute of Cancer Sciences, The University of Manchester, Manchester, UK The UK National Haemophilia Database, Manchester, UKSearch for more papers by this authorV. Nummi, V. Nummi Faculty of Medicine, University of Helsinki, Helsinki, Finland Laboratory Services, Coagulation Disorders Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, FinlandSearch for more papers by this authorR. Lassila, R. Lassila Faculty of Medicine, University of Helsinki, Helsinki, Finland Laboratory Services, Coagulation Disorders Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, FinlandSearch for more papers by this authorH. Xiang, H. Xiang The UK National Haemophilia Database, Manchester, UKSearch for more papers by this authorC. R. M. Hay, Corresponding Author C. R. M. Hay Charles.Hay@cmft.nhs.uk orcid.org/0000-0002-0162-6828 The Institute of Cancer Sciences, The University of Manchester, Manchester, UK The UK National Haemophilia Database, Manchester, UK Correspondence: Charles RM Hay, University Department of Haematology, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL. Tel.: 01612764727; fax: 0161 276 4814; e-mail: Charles.Hay@cmft.nhs.ukSearch for more papers by this author M. Scott, M. Scott The Institute of Cancer Sciences, The University of Manchester, Manchester, UK The UK National Haemophilia Database, Manchester, UKSearch for more papers by this authorV. Nummi, V. Nummi Faculty of Medicine, University of Helsinki, Helsinki, Finland Laboratory Services, Coagulation Disorders Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, FinlandSearch for more papers by this authorR. Lassila, R. Lassila Faculty of Medicine, University of Helsinki, Helsinki, Finland Laboratory Services, Coagulation Disorders Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, FinlandSearch for more papers by this authorH. Xiang, H. Xiang The UK National Haemophilia Database, Manchester, UKSearch for more papers by this authorC. R. M. Hay, Corresponding Author C. R. M. Hay Charles.Hay@cmft.nhs.uk orcid.org/0000-0002-0162-6828 The Institute of Cancer Sciences, The University of Manchester, Manchester, UK The UK National Haemophilia Database, Manchester, UK Correspondence: Charles RM Hay, University Department of Haematology, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL. Tel.: 01612764727; fax: 0161 276 4814; e-mail: Charles.Hay@cmft.nhs.ukSearch for more papers by this author First published: 18 May 2017 https://doi.org/10.1111/hae.13228Citations: 3Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume23, Issue3May 2017Pages e240-e243 RelatedInformation